PMID- 23740969 OWN - NLM STAT- MEDLINE DCOM- 20140224 LR - 20230618 IS - 1539-7262 (Electronic) IS - 0022-2275 (Print) IS - 0022-2275 (Linking) VI - 54 IP - 8 DP - 2013 Aug TI - Mechanistic target of rapamycin controls homeostasis of adipogenesis. PG - 2166-2173 LID - S0022-2275(20)37532-5 [pii] LID - 10.1194/jlr.M037705 [doi] AB - Signaling mediated by the mechanistic target of rapamycin (mTOR) is believed to play a critical and positive role in adipogenesis, based on pharmacological evidence and genetic manipulation of mTOR regulators and targets. However, there is no direct genetic evidence for an autonomous role of mTOR itself in preadipocyte differentiation. To seek such evidence, we employed a conditional knockdown approach to deplete mTOR in preadipocytes. Surprisingly, while knockdown of S6K1, a target of mTOR, impairs 3T3-L1 preadipocyte differentiation, reduction of mTOR levels leads to increased differentiation. This enhanced adipogenesis requires the remaining mTOR activity, as mTOR inhibitors abolish differentiation in the mTOR knockdown cells. We also found that mTOR knockdown elevates the levels of CCAAT/enhancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARgamma). Furthermore, partial reduction of mTOR levels alleviates inhibition of Akt by mTORC1 via IRS1, while at the same time maintaining its positive input through mTORC1 into the adipogenic program. The greater sensitivity of the IRS1-Akt pathway to mTOR levels provides a mechanism that explains the net outcome of enhanced adipogenesis through PPARgamma upon mTOR knockdown. Our observations reveal an unexpected role of mTOR in suppressing adipogenesis and suggest that mTOR governs the homeostasis of the adipogenic process by modulating multiple signaling pathways. FAU - Yoon, Mee-Sup AU - Yoon MS AD - Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801. FAU - Zhang, Chongben AU - Zhang C AD - Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801. FAU - Sun, Yuting AU - Sun Y AD - Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801. FAU - Schoenherr, Christopher J AU - Schoenherr CJ AD - Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801. FAU - Chen, Jie AU - Chen J AD - Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801. Electronic address: jiechen@illinois.edu. LA - eng GR - R01 GM089771/GM/NIGMS NIH HHS/United States GR - AR-048914/AR/NIAMS NIH HHS/United States GR - GM-089771/GM/NIGMS NIH HHS/United States GR - R56 AR048914/AR/NIAMS NIH HHS/United States GR - R01 AR048914/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130605 PL - United States TA - J Lipid Res JT - Journal of lipid research JID - 0376606 RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 90-kDa) RN - EC 2.7.11.1 (Rps6ka1 protein, mouse) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - 3T3-L1 Cells MH - Adipogenesis/*drug effects MH - Animals MH - Cell Differentiation/drug effects MH - Homeostasis/*drug effects MH - Mice MH - Ribosomal Protein S6 Kinases, 90-kDa/metabolism MH - Sirolimus/*pharmacology MH - Structure-Activity Relationship PMC - PMC3708366 OTO - NOTNLM OT - CCAAT/enhancer-binding protein alpha OT - adipocytes OT - mechanistic target of rapamycin complex 1 OT - peroxisome proliferator-activated receptor gamma EDAT- 2013/06/07 06:00 MHDA- 2014/02/25 06:00 PMCR- 2014/08/01 CRDT- 2013/06/07 06:00 PHST- 2013/06/07 06:00 [entrez] PHST- 2013/06/07 06:00 [pubmed] PHST- 2014/02/25 06:00 [medline] PHST- 2014/08/01 00:00 [pmc-release] AID - S0022-2275(20)37532-5 [pii] AID - m037705 [pii] AID - 10.1194/jlr.M037705 [doi] PST - ppublish SO - J Lipid Res. 2013 Aug;54(8):2166-2173. doi: 10.1194/jlr.M037705. Epub 2013 Jun 5.